Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding

Fertil Steril. 2009 Mar;91(3):933.e23-8. doi: 10.1016/j.fertnstert.2008.10.041. Epub 2008 Dec 4.

Abstract

Objective: To understand the pathogenesis of the androgen insensitivity syndrome.

Design: Familial case study.

Setting: Medical and Evolutionary Genetics Laboratory, Centre for Cellular and Molecular Biology, Hyderabad, India.

Patient(s): Two affected sisters and other unaffected family members.

Intervention(s): The hormone levels were measured by RIA. Histology was done by standard protocols. DNA isolation and direct DNA sequencing was undertaken for mutation identification. Site-directed mutagenesis was used for incorporation of mutation in the androgen receptor clone. Functional assays were done using COS-1 cell cultures.

Main outcome measure(s): Phenotype, hormone levels, DNA mutations, ligand binding, transactivation function of androgen-androgen receptor complex.

Result(s): The patients exhibited a female phenotype despite the 46,XY chromosome complement. Both of the affected individuals had higher levels of T and LH. C1760A (coding DNA sequence reference) substitution (Ala 586 Asp) in the AR gene was observed in all of the affected individuals. The mutation did not result in a loss of ligand binding but instead in almost complete loss of transactivation function.

Conclusion(s): The Ala 586 Asp mutation resulted in a complete loss of transactivation function of the androgen-androgen receptor complex but did not affect ligand binding. In vitro assays confirmed the pathogenic nature of this mutation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Androgen-Insensitivity Syndrome / genetics*
  • Androgen-Insensitivity Syndrome / metabolism
  • Androgen-Insensitivity Syndrome / pathology
  • Androgens / blood*
  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • DNA Mutational Analysis
  • Female
  • Follicle Stimulating Hormone, Human / blood
  • Genetic Predisposition to Disease
  • Humans
  • Karyotyping
  • Luteinizing Hormone / blood
  • Male
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Mutation*
  • Pedigree
  • Phenotype
  • Receptors, Androgen / genetics*
  • Receptors, Androgen / metabolism
  • Testosterone / blood
  • Transcriptional Activation*
  • Transfection
  • Young Adult

Substances

  • AR protein, human
  • Androgens
  • Follicle Stimulating Hormone, Human
  • Receptors, Androgen
  • Testosterone
  • Luteinizing Hormone